Alliancebernstein L.P. Purchases 120,928 Shares of KKR & Co. Inc. (NYSE:KKR)

Alliancebernstein L.P. grew its position in KKR & Co. Inc. (NYSE:KKR) by 16.7% in the fourth quarter, HoldingsChannel.com reports. The fund owned 845,636 shares of the asset manager’s stock after buying an additional 120,928 shares during the quarter. Alliancebernstein L.P.’s holdings in KKR & Co. Inc. were worth $125,078,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of KKR. AdvisorNet Financial Inc raised its position in KKR & Co. Inc. by 417.8% in the 4th quarter. AdvisorNet Financial Inc now owns 2,180 shares of the asset manager’s stock valued at $322,000 after purchasing an additional 1,759 shares during the last quarter. Whalen Wealth Management Inc. bought a new position in shares of KKR & Co. Inc. in the fourth quarter valued at about $667,000. Caldwell Investment Management Ltd. lifted its position in KKR & Co. Inc. by 2.9% during the 4th quarter. Caldwell Investment Management Ltd. now owns 212,400 shares of the asset manager’s stock worth $31,477,000 after buying an additional 5,900 shares in the last quarter. Jupiter Asset Management Ltd. grew its holdings in KKR & Co. Inc. by 50.9% during the 4th quarter. Jupiter Asset Management Ltd. now owns 114,184 shares of the asset manager’s stock worth $16,889,000 after acquiring an additional 38,524 shares during the last quarter. Finally, Sanctuary Advisors LLC increased its position in KKR & Co. Inc. by 31.1% in the 3rd quarter. Sanctuary Advisors LLC now owns 92,741 shares of the asset manager’s stock valued at $12,110,000 after acquiring an additional 22,007 shares in the last quarter. 76.26% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at KKR & Co. Inc.

In other news, major shareholder Genetic Disorder L.P. Kkr sold 6,000,000 shares of the firm’s stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $32.96, for a total transaction of $197,760,000.00. Following the sale, the insider now owns 19,260,971 shares of the company’s stock, valued at $634,841,604.16. This trade represents a 23.75 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 39.34% of the company’s stock.

KKR & Co. Inc. Stock Performance

Shares of NYSE:KKR opened at $120.99 on Thursday. The company has a market capitalization of $107.47 billion, a price-to-earnings ratio of 36.33, a P/E/G ratio of 1.00 and a beta of 1.77. The firm’s 50 day simple moving average is $133.56 and its 200 day simple moving average is $141.47. The company has a debt-to-equity ratio of 0.82, a current ratio of 0.07 and a quick ratio of 0.07. KKR & Co. Inc. has a fifty-two week low of $91.92 and a fifty-two week high of $170.40.

KKR & Co. Inc. Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Friday, February 14th were issued a $0.175 dividend. The ex-dividend date was Friday, February 14th. This represents a $0.70 annualized dividend and a yield of 0.58%. KKR & Co. Inc.’s dividend payout ratio (DPR) is presently 21.02%.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on KKR. Hsbc Global Res lowered shares of KKR & Co. Inc. from a “strong-buy” rating to a “hold” rating in a research report on Thursday, January 30th. Morgan Stanley decreased their price objective on KKR & Co. Inc. from $157.00 to $156.00 and set an “equal weight” rating on the stock in a research report on Thursday, February 6th. Barclays dropped their target price on KKR & Co. Inc. from $185.00 to $181.00 and set an “overweight” rating for the company in a research report on Wednesday, February 5th. Wells Fargo & Company raised KKR & Co. Inc. from an “equal weight” rating to an “overweight” rating and cut their price target for the company from $150.00 to $141.00 in a research note on Thursday, March 20th. Finally, Keefe, Bruyette & Woods lowered their price objective on KKR & Co. Inc. from $170.00 to $168.00 and set an “outperform” rating for the company in a research report on Monday, January 13th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $160.79.

KKR & Co. Inc. Company Profile

KKR & Co, Inc operates as an investment firm. It offers alternative asset management as well as capital markets and insurance solutions. The firm’s business segments include Asset Management and Insurance Business. The Asset Management segment engages in providing private equity, real assets, credit and liquid strategies, capital markets, and principal activities.